oxcarbazepine has been researched along with warfarin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Baysan, O; Nevruz, O; Yokuşoğlu, M | 1 |
Alobaidly, M; Amato, MG; Bates, DW; Gammal, RS; Hasan, S; Krier, JB; Reyes, DD; Seger, DL; Shah, SN | 1 |
1 review(s) available for oxcarbazepine and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for oxcarbazepine and warfarin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Warfarin resistance induced by oxcarbamazepine.
Topics: Blood Coagulation; Carbamazepine; Drug Interactions; Drug Resistance; Humans; Warfarin | 2009 |
Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
Topics: Biological Specimen Banks; Drug-Related Side Effects and Adverse Reactions; HLA-A Antigens; HLA-B Antigens; Humans; Oxcarbazepine; Pharmacogenetics; Vitamin K Epoxide Reductases; Warfarin | 2021 |